Valuation (57%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 44.16 | -0.52 |
PEG Ratio (TTM) | 5.30 | 3.91 |
P/S Ratio (TTM) | 1.11 | 1.39 |
P/B Ratio (TTM) | 3.65 | 5.17 |
P/FCF Ratio (TTM) | 10.63 | 2.93 |
Price to 5YR AVG Earnings Ratio | 20.80 | 25.64 |
Price to 5YR AVG FCF Ratio | 27.78 | 20.95 |
Profitability (35%) |
Company | Industry |
---|---|---|
ROA (TTM) | 2.48% | 4.99% |
ROE (TTM) | 7.90% | 7.10% |
Net Profit Margin (TTM) | 2.52% | 4.78% |
ROIC 5YR AVG | 15.33% | 14.08% |
Growth (80%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | 351.08% | 144.74% | 76.38% |
Revenue | 0.32% | 3.36% | 3.45% |
Net Income | 349.58% | 147.51% | 77.84% |
Cash Flow | 81.98% | 22.99% | 18.17% |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 1.41 | 1.98 |
Quick Ratio (TTM) | 0.76 | 1.18 |
D/E Ratio (TTM) | 0.55 | 1.97 |
Interest Coverage (TTM) | 10.31 | 10.97 |
Piotroski F-Score | 6 | 7 |
Altman Z-Score | 2.53 | 3.53 |
LTL to 5YR AVG FCF | 7.83 | 5.78 |
Shares Outstanding Growth 5YR AVG | 1.06% | -0.29% |